STAT3 and Src-YAP1 Inhibition Results in Greater Necitumumab Sensitivity in Lung Squamous Cell Carcinoma

Por: Verlicche, A, Karachaliou, N, Lazzari, C, Servat, CC, Capitan, AG, Servat, JC, Bertran-Alamillo, J, Vila, MAM, Chaib, I, Serrano, JLR, Dazzi, C, Cao, P and Rose, R

---

Publicada: 1 ene 2017

---

---

Filiaciones:
Verlicche, A:
 Osped Santa Maria Delle Croci, Oncol, Ravenna, Italy

Karachaliou, N:
 Hosp Univ Quiron Dexeus, Inst Oncol Dr Rosen IOR, Barcelona, Spain

Lazzari, C:
 Ist Europeo Oncol, Div Oncol Torac, Milan, Italy

Servat, CC:
 Ior Quiron Dexeus Univ Inst, Pangaea Biotech Sl, Lab Cellular & Mol Biol, Barcelona, Spain

Capitan, AG:
 Ior Quiron Dexeus Univ Inst, Pangaea Biotech Sl, Lab Cellular & Mol Biol, Barcelona, Spain

Servat, JC:
 Ior Quiron Dexeus Univ Inst, Pangaea Biotech Sl, Lab Cellular & Mol Biol, Barcelona, Spain

Bertran-Alamillo, J:
 Ior Quiron Dexeus Univ Inst, Pangaea Biotech Sl, Lab Cellular & Mol Biol, Barcelona, Spain

Vila, MAM:
 Ior Quiron Dexeus Univ Inst, Pangaea Biotech Sl, Lab Cellular & Mol Biol, Barcelona, Spain

:
 Inst Invest Ciencies Germans Trias & Pujol, Lab Cellular & Mol Biol, Badalona, Spain

:
 Catalan Inst Oncol, Lab Cellular & Mol Biol, Badalona, Spain

 Inst Invest Ciencies Germans Trias & Pujol, Badalona, Spain

Dazzi, C:
 S Maria Delle Croci Hosp, Med Oncol, Ravenna, Italy

Cao, P:
 Nanjing Univ Chinese Med, Hosp Integrated Tradit Chinese & Western Med, Lab Cellular & Mol Biol, Nanjing, Jiangsu, Peoples R China

:
 Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Barcelona, Spain